Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

AI could help predict sudden cardiac death in hereditary heart disease patients

NCT ID NCT07257289

Knowledge-focused Sponsor: Nantes University Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study aims to improve how doctors predict the risk of sudden cardiac death or heart failure in people with inherited heart diseases. Researchers will use artificial intelligence to analyze data from 1,000 participants, including medical history, ECGs, imaging, genetic tests, and biomarkers. The goal is to better identify who truly needs a defibrillator and who can avoid unnecessary procedures.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could lead to a more accurate way to predict who is at risk of sudden cardiac death or heart failure, helping doctors decide who needs a defibrillator.
What could go wrong
This is an observational study, not a treatment trial. The AI model may not prove accurate enough to change clinical practice, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 1,000 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2026

Expected to finish

Dec 2036

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

All adult and minor patients with hereditary heart disease or cardiomyopathies and their relatives.

Ages

1 year to 100 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria : I. hereditary heart disease II. All relatives of patients III. Patients referred to the reference centre for suspected hereditary rhythm disorders or cardiomyopathies IV. Written consent V. social security scheme Exclusion Criteria : I. Patients participating in a therapeutic trial that may interfere with the research results II. Patients under guardianship or curatorship.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cardiomyopathy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cardiac rhythm disease cardiogenetic disease cardiomyopathy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Hereditary heart diseases

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    15 sites in 3 countries. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • CHU de Bordeaux

    NOT_YET_RECRUITING

    Bordeaux, France

  • CHU de Brest

    NOT_YET_RECRUITING

    Brest, France

  • CHU de Clermont-Ferrand

    NOT_YET_RECRUITING

    Clermont-Ferrand, France

  • CHU de Dijon

    NOT_YET_RECRUITING

    Dijon, France

  • CHU de La Rochelle

    NOT_YET_RECRUITING

    La Rochelle, France

  • CHU de Limoges

    NOT_YET_RECRUITING

    Limoges, France

  • CHU de Montpellier

    NOT_YET_RECRUITING

    Montpellier, France

  • CHU de Nantes

    RECRUITING

    Nantes, 44093, France

  • CHU de Poitiers

    NOT_YET_RECRUITING

    Poitiers, France

  • CHU de Rennes

    NOT_YET_RECRUITING

    Rennes, France

  • CHU de Strasbourg

    NOT_YET_RECRUITING

    Strasbourg, France

  • CHU de Toulouse

    NOT_YET_RECRUITING

    Toulouse, France

  • CHU de Tours

    NOT_YET_RECRUITING

    Tours, France

  • CHU de la Martinique

    NOT_YET_RECRUITING

    Fort-de-France, Martinique

  • CHU de la Réunion

    NOT_YET_RECRUITING

    Saint-Pierre, Reunion

More trials for these conditions

Other studies related to the condition(s) this trial covers.